Defense Argues to Exclude Finance Evidence in Tylenol MDL
Attorneys for the plaintiff and drugmaker McNeil Consumer Healthcare went back and forth Tuesday in federal court over motions to exclude pieces of evidence—some related to profit margins and lobbying—in the first bellwether trial in the Philadelphia-based Tylenol multidistrict litigation.
November 17, 2015 at 10:11 AM
5 minute read
Attorneys for the plaintiff and drugmaker McNeil Consumer Healthcare went back and forth Tuesday in federal court over motions to exclude pieces of evidence—some related to profit margins and lobbying—in the first bellwether trial in the Philadelphia-based Tylenol multidistrict litigation.
Argument in the case took place during a status conference before U.S. District Judge Lawrence F. Stengel of the Eastern District of Pennsylvania. The conference came days after a series of rulings from Stengel denying McNeil's requests to toss the case.
The wrongful-death suit is slated to go to trial in late spring and was filed by plaintiff Rana Terry, whose sister, Denice Hayes, died of liver failure in 2010 allegedly caused by the consumption of Extra Strength Tylenol.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250